Literature DB >> 19853549

Lessons from development: A role for asymmetric stem cell division in cancer.

Anne E Powell1, Chia-Yi Shung, Katherine W Saylor, Karin A Müllendorff, Karin A Müllendorf, Joseph B Weiss, Melissa H Wong.   

Abstract

Asymmetric stem cell division has emerged as a major regulatory mechanism for physiologic control of stem cell numbers. Reinvigoration of the cancer stem cell theory suggests that tumorigenesis may be regulated by maintaining the balance between asymmetric and symmetric cell division. Therefore, mutations affecting this balance could result in aberrant expansion of stem cells. Although a number of molecules have been implicated in regulation of asymmetric stem cell division, here, we highlight known tumor suppressors with established roles in this process. While a subset of these tumor suppressors were originally defined in developmental contexts, recent investigations reveal they are also lost or mutated in human cancers. Mutations in tumor suppressors involved in asymmetric stem cell division provide mechanisms by which cancer stem cells can hyperproliferate and offer an intriguing new focus for understanding cancer biology. Our discussion of this emerging research area derives insight from a frontier area of basic science and links these discoveries to human tumorigenesis. This highlights an important new focus for understanding the mechanism underlying expansion of cancer stem cells in driving tumorigenesis. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853549      PMCID: PMC2818177          DOI: 10.1016/j.scr.2009.09.005

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  52 in total

1.  Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.

Authors:  Xuefeng Lu; Xiujing Feng; Xiaobo Man; Guang Yang; Liang Tang; Dan Du; Fan Zhang; Haixin Yuan; Qin Huang; Zhe Zhang; Yinkun Liu; Dennis Strand; Zhengjun Chen
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

2.  Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells.

Authors:  Joerg Betschinger; Karl Mechtler; Juergen A Knoblich
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

3.  APC mutations in sporadic medulloblastomas.

Authors:  H Huang; B M Mahler-Araujo; A Sankila; L Chimelli; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

4.  Genomic rearrangements of the APC tumor-suppressor gene in familial adenomatous polyposis.

Authors:  L K Su; G Steinbach; J C Sawyer; M Hindi; P A Ward; P M Lynch
Journal:  Hum Genet       Date:  2000-01       Impact factor: 4.132

5.  Frequent alteration of p63 expression in human primary bladder carcinomas.

Authors:  B J Park; S J Lee; J I Kim; S J Lee; C H Lee; S G Chang; J H Park; S G Chi
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

6.  The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors.

Authors:  Jens C Schwamborn; Eugene Berezikov; Juergen A Knoblich
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

Review 7.  Upsides and downsides to polarity and asymmetric cell division in leukemia.

Authors:  E D Hawkins; S M Russell
Journal:  Oncogene       Date:  2008-11-24       Impact factor: 9.867

8.  Linking cell cycle to asymmetric division: Aurora-A phosphorylates the Par complex to regulate Numb localization.

Authors:  Frederik Wirtz-Peitz; Takashi Nishimura; Juergen A Knoblich
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

9.  Loss of heterozygosity of TRIM3 in malignant gliomas.

Authors:  Jean-Louis Boulay; Urs Stiefel; Elisabeth Taylor; Béatrice Dolder; Adrian Merlo; Frank Hirth
Journal:  BMC Cancer       Date:  2009-02-27       Impact factor: 4.430

10.  TRIM32 is an E3 ubiquitin ligase for dysbindin.

Authors:  Matthew Locke; Caroline L Tinsley; Matthew A Benson; Derek J Blake
Journal:  Hum Mol Genet       Date:  2009-04-06       Impact factor: 6.150

View more
  8 in total

1.  Mouse oocyte, a paradigm of cancer cell.

Authors:  Marie-Emilie Terret; Agathe Chaigne; Marie-Hélène Verlhac
Journal:  Cell Cycle       Date:  2013-09-30       Impact factor: 4.534

2.  Scribble acts as an oncogene in Eμ-myc-driven lymphoma.

Authors:  E D Hawkins; J Oliaro; K M Ramsbottom; A Newbold; P O Humbert; R W Johnstone; S M Russell
Journal:  Oncogene       Date:  2015-05-18       Impact factor: 9.867

Review 3.  Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.

Authors:  Beatrice Aramini; Valentina Masciale; Giulia Grisendi; Federica Bertolini; Michela Maur; Giorgia Guaitoli; Isca Chrystel; Uliano Morandi; Franco Stella; Massimo Dominici; Khawaja Husnain Haider
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

Review 4.  Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities.

Authors:  Maximilian Stahl; Tae Kon Kim; Amer M Zeidan
Journal:  World J Stem Cells       Date:  2016-10-26       Impact factor: 5.326

5.  Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis.

Authors:  Hojung Lee; Hyekyung Lee; Yong Kyun Cho
Journal:  Diagn Pathol       Date:  2017-02-17       Impact factor: 2.644

Review 6.  Metastasis and MAPK Pathways.

Authors:  Mateusz Kciuk; Adrianna Gielecińska; Adrianna Budzinska; Mariusz Mojzych; Renata Kontek
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

7.  Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG.

Authors:  Giulia Lombardi; Roberta Valeria Latorre; Alessandro Mosca; Diego Calvanese; Luisa Tomasello; Christian Boni; Manuela Ferracin; Massimo Negrini; Nader Al Dewik; Mohamed Yassin; Mohamed A Ismail; Bruno Carpentieri; Claudio Sorio; Paola Lecca
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

8.  TNIK signaling imprints CD8+ T cell memory formation early after priming.

Authors:  Carla A Jaeger-Ruckstuhl; Magdalena Hinterbrandner; Sabine Höpner; Colin E Correnti; Ursina Lüthi; Olivier Friedli; Stefan Freigang; Mohamad F Al Sayed; Elias D Bührer; Michael A Amrein; Christian M Schürch; Ramin Radpour; Carsten Riether; Adrian F Ochsenbein
Journal:  Nat Commun       Date:  2020-04-02       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.